Dihydroergotamine: role in the treatment of migraine

By Schürks Markus  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1141-1148

Informa Healthcare

Access to resources Recommend Favorite

Dihydroergotamine mesilate: First report of posterior reversible encephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dihydroergotamine mesilate/methysergide: Valvular heart disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1396, 2012-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?

By Morren John A   Galvez-Jimenez Nestor  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3085-3093

Informa Healthcare

Access to resources Recommend Favorite

Elderly Patients with Migraine: An Open-Label Study on Prophylaxis Therapy with Levetiracetam

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 31-34

Bentham Science Publishers

Access to resources Recommend Favorite